7 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... inhibitors in CVD ... OUTCOME - Empagliflozin ... DAPA-CKD - Dapagliflozin ... #inhibitors #EBM
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... -2 inhibitors - ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes ... #Inhibitors #pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... gliflozin): • Empagliflozin ... loss (~2-3kg) • Empagliflozin ... • Euglycemic diabetic ... #Summary #DM2 #diabetes
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... alpha-glucosidase inhibitor ... receptor agonist SGLT2i ... type 2 diabetes; ... #Diabetes Management
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... modulate sodium ... SGLT2 inhibitors ... treatment of type II diabetes ... , #empagliflozin
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... Improved outcomes in CKD ... EricsMedicalLectures/featured #diabetes
Perioperative Medications - Which Medications to Hold or Continue?
Aspirin - Continue
 • Aspirin should be continued
other than HF, CAD ... morning of surgery Empagliflozin ... (SGLT2 Inhibitors